Search Results 81-90 of 18291 for total bilirubin

1. Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma - Mayo Clinic

   - Total bilirubin =< 1.5 x upper limit of normal (ULN) for age (within 7 ... bilirubin must be < 3 x ULN for age. - Note: For the purpose of this study ...

2. MicroOrganoSphere Drug Screen Pilot Trial In Colorectal Cancer (CRC) - Mayo Clinic

   Total bilirubin < 1.5 x ULN (if total bilirubin ≥ 1.5 x ULN then the subject may participate if the direct bilirubin is ≤ 1.5 x ULN); 6. Creatinine ...

3. A Study to Evaluate Infigratinib to Treat Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302) - Mayo Clinic

   Total bilirubin > 1.5 × upper limit of normal (ULN) of the testing laboratory (for subjects with documented Gilbert syndrome, direct bilirubin must be ...

4. Efficacy And Safety Of Treatment With Alpelisib Plus Endocrine Therapy In Patients With HR+, HER2-negative ABC, With PIK3CA Mutations, Whose Disease Has Progressed On Or After CDK 4/6 Treatment With An Aromatase Inhibitor (AI) Or Fulvestrant - Mayo Clinic

   Total serum bilirubin < 2 x ULN (any elevated bilirubin should be asymptomatic at enrollment) except for patients with Gilbert's syndrome who may only be ...

5. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

   Total bilirubin ≤ 1.5 × the upper limit of normal (ULN) (subjects with Gilbert's Syndrome are allowed if direct bilirubin is within normal limits); ...

6. Phase I Study Of LB-100 With Docetaxel In Solid Tumors - Mayo Clinic

   Participation eligibility · Part 1 only: plasma total bilirubin ≤ 1.5 mg/dL, alanine transaminase (ALT) and aspartate transaminase (AST) ≤ 2.5 X ULN (upper ...

7. A Study To Find Out Whether BI 1015550 Improves Lung Function In People With Progressive Fibrosing Interstitial Lung Disease (PF-ILDs) - Mayo Clinic

   limit of normal (ULN) or total Bilirubin > 1.5 x ULN at Visit 1. Additional Exclusion Criteria may apply. Eligibility last updated 7/7/22. Questions ...

8. Testing The Addition Of Total Ablative Therapy To Usual Systemic Therapy Treatment For Limited Metastatic Colorectal Cancer, The ERASur Study - Mayo Clinic

   - REGISTRATION (STEP 1): Total bilirubin =< 1.5 x ULN - REGISTRATION (STEP 1): Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic transaminase ...

9. A Study Of Carboplatin, Cabazitaxel And Abiraterone In High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) - Mayo Clinic

   Total bilirubin < ULN; or total bilirubin ≤ 3.0 x ULN or direct bilirubin ≤ 1.5 x ULN in patients with well‐documented Gilbert's Syndrome. Sexually active ...

10. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) unless due to Gilbert's disease. If total bilirubin is > 1.5 x ULN, a direct bilirubin ...